Tango Therapeutics Inc [TNGX] stock prices are down -4.16% to $7.15 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TNGX shares have gain 4.53% over the last week, with a monthly amount drifted -13.86%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Tango Therapeutics Inc [NASDAQ: TNGX] stock has seen the most recent analyst activity on July 17, 2024, when Jefferies initiated its Buy rating and assigned the stock a price target of $19. On February 12, 2024, Piper Sandler initiated with a Overweight rating and assigned a price target of $18 on the stock. B. Riley Securities started tracking the stock assigning a Buy rating and suggested a price target of $16 on December 08, 2023. H.C. Wainwright upgraded its rating to a Buy but $10 remained the price target by the analyst firm on October 20, 2022. SVB Leerink started tracking with a Outperform rating for this stock on September 20, 2021, and assigned it a price target of $25.
The stock price of Tango Therapeutics Inc [TNGX] has been fluctuating between $6.33 and $13.01 over the past year. Currently, Wall Street analysts expect the stock to reach $14.67 within the next 12 months. Tango Therapeutics Inc [NASDAQ: TNGX] shares were valued at $7.15 at the most recent close of the market. An investor can expect a potential return of 105.17% based on the average TNGX price forecast.
Analyzing the TNGX fundamentals
The Tango Therapeutics Inc [NASDAQ:TNGX] reported sales of 42.51M for trailing twelve months, representing a surge of 36.15%. Gross Profit Margin for this corporation currently stands at 0.94% with Operating Profit Margin at -3.12%, Pretax Profit Margin comes in at -2.74%, and Net Profit Margin reading is -2.74%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -0.45 and Total Capital is -0.39. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.95 points at the first support level, and at 6.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.41, and for the 2nd resistance point, it is at 7.66.
Ratios To Look Out For
It’s worth pointing out that Tango Therapeutics Inc [NASDAQ:TNGX]’s Current Ratio is 7.49. In addition, the Quick Ratio stands at 7.49 and the Cash Ratio stands at 1.18. Considering the valuation of this stock, the price to sales ratio is 18.02, the price to book ratio is 3.09.
Transactions by insiders
Recent insider trading involved Third Rock Ventures IV, L.P., 10% Owner, that happened on Sep 13 ’24 when 67400.0 shares were sold. Affiliate, Third Rock Ventures IV, L.P. completed a deal on Sep 13 ’24 to buy 67400.0 shares. Meanwhile, 10% Owner Third Rock Ventures IV, L.P. sold 75000.0 shares on Sep 05 ’24.
